Affinity Bio Partners, LLC

Affinity Bio Partners, LLC Clinical Research Organization that provides project management, monitoring, outsourcing/relationshi

Clinical Research Organization that provides project management, monitoring, outsourcing/relationship management, medical writing etc

08/08/2023

Congratulations to our CEO, Christina DiArcangelo!

With an impressive and expansive portfolio, Christina DiArcangelo stands as a leading figure in medical cannabis biotech research, patient advocacy, and technology innovation. DiArcangelo’s journey began in 2016, sparked by groundbreaking academic studies and a desire to create meaningful change in patients’ lives. Her formidable presence in the industry has since been marked by relentless innovation, passion, and purpose.

Read the full article: https://forbesmorocco.com/2023/08/08/christina-diarcangelo-trailblazing-through-medical-cannabis-biotech-and-beyond/

07/04/2023

“Happy 4th of July! Enjoy the day making memories!” 🇺🇸Christina DiArcangelo

Zelira partnered with Pennsylvania based Global CRO, Affinity Bio Partners, to manage this clinical trial. Christina DiA...
05/31/2023

Zelira partnered with Pennsylvania based Global CRO, Affinity Bio Partners, to manage this clinical trial. Christina DiArcangelo, CEO of Affinity Bio Partners said:

I am very happy with the outcome of our first-ever head-to-head clinical trial focusing on cannabinoids in the treatment of diabetic neuropathy.

The operational complexities of conducting cannabinoid studies, including adherence to stringent guidelines, Good Clinical Practice (GCP), and regulatory requirements, were effectively and successfully managed.

I wholeheartedly applaud Zelira for their bold commitment to advancing
the field of cannabinoid drug development and exploring pharmaceutical compounds that can bring relief to countless patients.

Together with our esteemed partners, Spectral Analytics Precision Tele-Monitoring and Affinity Patient Advocacy, we successfully completed this study.

This achievement marks the realisation of a long-cherished vision in the space of global cannabinoid biotechnology, propelling us forward with newfound confidence to design and pursue formal trials in this space.

Our objective remains the development of pharmaceutical industry quality, innovative and effective new drug treatments, offering hope and improved quality of life for patients in need.

The topline results for Zelira’s diabetic nerve pain trial are outlined below. The study evaluated the efficacy, safety, and tolerability of Zelira’s proprietary patent protected ZLT-L-007, against the well-known drug Lyrica® (Pregabalin).

05/29/2023

Happy Memorial Day! We thank you all for your services and sacrifices.

04/26/2023

Hello & welcome to today's episode of I Am Christina DiArcangelo! Today we meet and speak with Dan Sfera, who I consider a Clinical Trials Guru. Recently starting his latest research clinic in Yuma, Arizona Dan shares why he was drawn to the biotech space and how he feels he has a great opportunity in combining where excitement meets opportunity in what may be his last start-up facility. The industry is looking for minorities and underserved communities and he connects those opportunities with ensuring that he remains at his core purpose of providing patient safety at the forefront of all of his endeavors.



https://iamchristinadiarcangelo.buzzsprout.com/1778580/12673936-patient-safety-comes-first-with-dan-sfera

04/20/2023

Repost Christina DiArcangelo

“As most of you that know me or know of my work are aware that the majority of my career I have spent in the traditional global biotech and pharmaceutical industries. I remember deciding years ago to leap into the cannabinoid clinical research space prior to it being popular or main stream. I was criticized professionally and personally when I made the decision to enter the cannabinoid clinical research space by both professionals and personal people that knew me. I took a massive pay cut and talked about the need for clinical research in cannabinoids every chance I got. People were annoyed with me at times but I still persevered. Based on the clinical research that I had been exposed too, I had seen data and knew that there was a lot of potential for cannabinoids as a nutraceutical to become a therapeutic treatment for patients.These observations were made prior to my diagnosis of two autoimmune diseases in 2018. When I was diagnosed with my first autoimmune disease, I decided to try CBD and CBN tincture. It was helping me with my issues which was exciting for me to observe. This are not claims, just my personal experience. Later that year, my pain got extensively worse and I registered for my medical card in PA. I was somewhat THC naive but knew based on the research that I needed help with my pain and inflammation which I was suffering from on a daily basis. A little while later, I was diagnosed with my second autoimmune disease. I decided with the second diagnosis that I needed to make some drastic changes in my life. I started exercising daily, consuming cannabinoids daily, meditating more often, started Keto which then turned into an anti-inflammatory diet, watched my triggers closely and started removing toxic people from my life, began therapy and decided to end my marriage. All of these things, have made major changes in my life to my benefit. While my journey has not been easy and I struggle with my health daily; I am grateful for the medicinal powers of the plant. I am so thankful that I decided to move into this industry through clinical research which has led to patient advocacy, the development of AI Technology, and discussion advancements on my podcast sow, I am Christina DiArcangelo and launched The DiArc e-magazine as well. Every day, we are working towards making a difference in patients’ lives and providing them with the opportunity to take back control of their health. The picture below is a side by side of me in 2019 on the left and 2022 at a photoshoot. In the picture from 2019, I was inflamed, overweight, depressed, not happy, and anxious. I was a shell of a person. My smile was fake and I was hiding a huge amount of pain from those that knew me. Due to all of this, I will continue to advance clinical research, advocate for patients, push for strong data through technology, monitor patients as well as develop treatments for them. It is my duty to do so. The plant has so many powerful healing properties that still need to be further researched.” 🌱Christina DiArcangelo #420

04/06/2023

Meet our Co-Worker at Affinity Bio Partners, Lajitha, She is an amazing, hardworking, and mission driven woman. We are pleased to have her in our Magazine for Women History Month. ✨️ This is a tribute to all the women out there who are constantly working hard ! 🌟 Get yourself featured in The DiArc Magazine, write to us at Nitika@christinadiarcangelo.com or info@christinadiarcangelo.com

04/01/2023

We support patients with autism and their families. We are here for you through clinical studies with Affinity Bio Partners, LLC, free patient advocacy services with Affinity Patient Advocacy, and perpetual tele-monitoring and CannaBot access through Spectral Analytics Precision Tele-monitoring. We are here for you! Much love to all of you!

**p

Our CEO, Christina DiArcangelo’s mother and brother both suffered from Bi-Polar Disease. Today, we think of all the pati...
03/31/2023

Our CEO, Christina DiArcangelo’s mother and brother both suffered from Bi-Polar Disease. Today, we think of all the patients that have lost their lives too soon from Bipolar Disease and those that continue to fight forward as a Warrior. Bipolar disease is one that is commonly misunderstood and these patients all deserve a voice.

Affinity Bio Partners is the leading pioneers in clinical research.  We help our clients expedite timelines and operatio...
03/16/2023

Affinity Bio Partners is the leading pioneers in clinical research. We help our clients expedite timelines and operationalize the most efficient clinical studies.

03/08/2023

Happy International Women’s Day!

Happy President’s Day!               #2023
02/20/2023

Happy President’s Day!

#2023

Address

Spring City, PA
19475

Alerts

Be the first to know and let us send you an email when Affinity Bio Partners, LLC posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Affinity Bio Partners, LLC:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram